OBJECTIVE: To provide a training tool to address the technical challenges of robot-assisted laparoscopic partial nephrectomy, we created silicone renal tumor models using 3-dimensional printed molds of a patient's kidney with a mass. In this study, we assessed the face, content, and construct validity of these models. MATERIALS AND METHODS: Surgeons of different training levels completed 4 simulations on silicone renal tumor models. Participants were surveyed on the usefulness and realism of the model as a training tool. Performance was measured using operation-specific metrics, self-reported operative demands (NASA Task Load Index [NASA TLX]), and blinded expert assessment (Global Evaluative Assessment of Robotic Surgeons [GEARS]). RESULTS: Twenty-four participants included attending urologists, endourology fellows, urology residents, and medical students. Post-training surveys of expert participants yielded mean results of 79.2 on the realism of the model's overall feel and 90.2 on the model's overall usefulness for training. Renal artery clamp times and GEARS scores were significantly better in surgeons further in training (P ≤.005 and P ≤.025). Renal artery clamp times, preserved renal parenchyma, positive margins, NASA TLX, and GEARS scores were all found to improve across trials (P <.001, P = .025, P = .024, P ≤.020, and P ≤.006, respectively). CONCLUSION: Face, content, and construct validity were demonstrated in the use of a silicone renal tumor model in a cohort of surgeons of different training levels. Expert participants deemed the model useful and realistic. Surgeons of higher training levels performed better than less experienced surgeons in various study metrics, and improvements within individuals were observed over sequential trials. Future studies should aim to assess model predictive validity, namely, the association between model performance improvements and improvements in live surgery.
OBJECTIVE: To provide a training tool to address the technical challenges of robot-assisted laparoscopic partial nephrectomy, we created siliconerenal tumor models using 3-dimensional printed molds of a patient's kidney with a mass. In this study, we assessed the face, content, and construct validity of these models. MATERIALS AND METHODS: Surgeons of different training levels completed 4 simulations on siliconerenal tumor models. Participants were surveyed on the usefulness and realism of the model as a training tool. Performance was measured using operation-specific metrics, self-reported operative demands (NASA Task Load Index [NASA TLX]), and blinded expert assessment (Global Evaluative Assessment of Robotic Surgeons [GEARS]). RESULTS: Twenty-four participants included attending urologists, endourology fellows, urology residents, and medical students. Post-training surveys of expert participants yielded mean results of 79.2 on the realism of the model's overall feel and 90.2 on the model's overall usefulness for training. Renal artery clamp times and GEARS scores were significantly better in surgeons further in training (P ≤.005 and P ≤.025). Renal artery clamp times, preserved renal parenchyma, positive margins, NASA TLX, and GEARS scores were all found to improve across trials (P <.001, P = .025, P = .024, P ≤.020, and P ≤.006, respectively). CONCLUSION: Face, content, and construct validity were demonstrated in the use of a siliconerenal tumor model in a cohort of surgeons of different training levels. Expert participants deemed the model useful and realistic. Surgeons of higher training levels performed better than less experienced surgeons in various study metrics, and improvements within individuals were observed over sequential trials. Future studies should aim to assess model predictive validity, namely, the association between model performance improvements and improvements in live surgery.
Authors: Bin Zheng; Xianta Jiang; Geoffrey Tien; Adam Meneghetti; O Neely M Panton; M Stella Atkins Journal: Surg Endosc Date: 2012-04-24 Impact factor: 4.584
Authors: Daniel R Chang; Ryan P Lin; Sarah Bowe; Leon Bunegin; Erik K Weitzel; Kevin C McMains; Thomas Willson; Philip G Chen Journal: Laryngoscope Date: 2016-12-21 Impact factor: 3.325
Authors: Maria C Mir; Cesar Ercole; Toshio Takagi; Zhiling Zhang; Lily Velet; Erick M Remer; Sevag Demirjian; Steven C Campbell Journal: J Urol Date: 2015-01-29 Impact factor: 7.450
Authors: Nicole Wake; Temitope Rude; Stella K Kang; Michael D Stifelman; James F Borin; Daniel K Sodickson; William C Huang; Hersh Chandarana Journal: Abdom Radiol (NY) Date: 2017-05
Authors: Friedrich-Carl von Rundstedt; Jason M Scovell; Smriti Agrawal; Jacques Zaneveld; Richard E Link Journal: BJU Int Date: 2016-12-10 Impact factor: 5.588
Authors: Giorgio Gandaglia; Praful Ravi; Firas Abdollah; Abd-El-Rahman M Abd-El-Barr; Andreas Becker; Ioana Popa; Alberto Briganti; Pierre I Karakiewicz; Quoc-Dien Trinh; Michael A Jewett; Maxine Sun Journal: Can Urol Assoc J Date: 2014-07 Impact factor: 1.862
Authors: İlkan Tatar; Emre Huri; İlker Selçuk; Young Lee Moon; Alberto Paoluzzi; Andreas Skolarikos Journal: Turk J Med Sci Date: 2019-10-24 Impact factor: 0.973
Authors: Stefano Puliatti; Ahmed Eissa; Enrico Checcucci; Pietro Piazza; Marco Amato; Stefania Ferretti; Simone Scarcella; Juan Gomez Rivas; Mark Taratkin; Josè Marenco; Ines Belenchon Rivero; Karl-Friedrich Kowalewski; Giovanni Cacciamani; Ahmed El-Sherbiny; Ahmed Zoeir; Abdelhamid M El-Bahnasy; Ruben De Groote; Alexandre Mottrie; Salvatore Micali Journal: Asian J Urol Date: 2022-06-01
Authors: Andrew J Cohen; German Patino; Mehran Mirramezani; Sudarshan Srirangapatanam; Anas Tresh; Bhagat Cheema; Jenny Tai; Dylan Romero; Anthony Enriquez; Laurence S Baskin; Shawn C Shadden; Benjamin N Breyer Journal: PLoS One Date: 2020-11-11 Impact factor: 3.240